scholarly article | Q13442814 |
P50 | author | Tim Friede | Q58452336 |
Nigel Stallard | Q43132046 | ||
Nick Parsons | Q53112989 | ||
Cornelia U Kunz | Q55473027 | ||
P2093 | author name string | Susan Todd | |
P2860 | cites work | Combining multiple comparisons and modeling techniques in dose-response studies | Q81145375 |
Adaptive designs in clinical drug development--an Executive Summary of the PhRMA Working Group | Q83841990 | ||
On closed testing procedures with special reference to ordered analysis of variance | Q29041733 | ||
Testing and estimation in flexible group sequential designs with adaptive treatment selection | Q36327917 | ||
Confirmatory seamless phase II/III clinical trials with hypotheses selection at interim: general concepts | Q36593604 | ||
Adaptive designs for confirmatory clinical trials | Q37389417 | ||
Effects of a novel aldosterone synthase inhibitor for treatment of primary hypertension: results of a randomized, double-blind, placebo- and active-controlled phase 2 trial | Q38483164 | ||
A comparison of methods for treatment selection in seamless phase II/III clinical trials incorporating information on short-term endpoints | Q42130183 | ||
Adaptive designs for pivotal trials: discussion points from the PSI Adaptive Design Expert Group. | Q42602448 | ||
An adaptive seamless phase II/III design for oncology trials with subpopulation selection using correlated survival endpoints | Q44262116 | ||
Interim analysis of continuous long-term endpoints in clinical trials with longitudinal outcomes. | Q44446094 | ||
A confirmatory seamless phase II/III clinical trial design incorporating short-term endpoint information | Q45374094 | ||
Adaptive sample size calculations in group sequential trials | Q47213254 | ||
Designing a seamless phase II/III clinical trial using early outcomes for treatment selection: an application in multiple sclerosis | Q48152166 | ||
Time-to-event analysis with treatment arm selection at interim. | Q51534010 | ||
Evaluation of experiments with adaptive interim analyses. | Q52364596 | ||
Multiplicity and flexibility in clinical trials. | Q53025596 | ||
A Multiple Comparison Procedure for Comparing Several Treatments with a Control | Q56838307 | ||
Recursive Combination Tests | Q57305829 | ||
A group-sequential design for clinical trials with treatment selection | Q57430672 | ||
P433 | issue | 4 | |
P921 | main subject | phase II clinical trial | Q42824440 |
phase III clinical trial | Q42824827 | ||
P304 | page(s) | 238-246 | |
P577 | publication date | 2014-05-02 | |
P1433 | published in | Pharmaceutical Statistics | Q7180744 |
P1476 | title | Data-driven treatment selection for seamless phase II/III trials incorporating early-outcome data | |
P478 | volume | 13 |
Q38963322 | Adaptive graph-based multiple testing procedures |
Q41883714 | Blinded versus unblinded estimation of a correlation coefficient to inform interim design adaptations. |
Q86499109 | Clinical trials submitted to the JID: place your bet and show us your hand |
Q39073427 | Development of a Bayesian response-adaptive trial design for the Dexamethasone for Excessive Menstruation study |
Q34465354 | Sarilumab Plus Methotrexate in Patients With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate: Results of a Phase III Study |
Q41857207 | Type I error rates of multi-arm multi-stage clinical trials: strong control and impact of intermediate outcomes. |
Search more.